schliessen

Filtern

 

Bibliotheken

9.

Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin-paclitaxel.
by Arrieta, Oscar

The European journal of health economics : HEPAC : health economics in prevention and care, September 2016, Vol.17(7), pp.855-863

12

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 25 Hits

Remove Filters